Learn / SCTX
NASDAQ: SCTX
Scribe Therapeutics (SCTX) stock, explained like you're 5
Scribe Therapeutics trades on the Nasdaq under the ticker SCTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 401 million dollars.
- Ticker
- SCTX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 401 million dollars
Is Scribe Therapeutics a small, medium or large cap company?
No. Scribe Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 401 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Scribe Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves SCTX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Scribe Therapeutics (SCTX) Stock Price, News & Analysis (Stock Titan)
- Scribe Therapeutics: Underrated In Vivo Gene Therapy Developer With Near Term Catalyst (Seeking Alpha)
- Scribe Therapeutics Inc. (SCTX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Scribe Therapeutics: SCTX Stock Price Quote & News (Robinhood)
- Cathie Wood’s ARK adds to Scribe Therapeutics stock position (Investing.com)
Follow SCTX in your daily brief
Each trading day at 5 PM ET we post what happened to Scribe Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow SCTX
Questions about Scribe Therapeutics stock
What does Scribe Therapeutics do?
Scribe Therapeutics trades on the Nasdaq under the ticker SCTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 401 million dollars.
What is the ticker symbol for Scribe Therapeutics?
Scribe Therapeutics trades under the ticker SCTX on the Nasdaq.
What is Scribe Therapeutics's market cap?
Scribe Therapeutics is a small cap stock with a market cap of about 401 million dollars.
How does Scribe Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves SCTX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow SCTX stock every day?
Add SCTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.